Xenon Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada.
Xenon Pharmaceuticals stock last closed at $40.50, up 1% from the previous day, and has increased 2.48% in one year. It has overperformed other stocks in the Biotechnology industry by 0.25 percentage points. Xenon Pharmaceuticals stock is currently +44.72% from its 52-week low of $27.99, and -20.57% from its 52-week high of $50.99.
There are currently 75.43M XENE shares outstanding. The market capitalization of XENE is $3.06B. In the past 24 hours, 320,772 XENE shares were traded.
How to Buy Xenon Pharmaceuticals Stock
Wondering how to invest in Xenon Pharmaceuticals stock? Here's how.
Choose where to buy Xenon Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Xenon Pharmaceuticals stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your brokerage account: Select your payment method and add your details.
Analyze Xenon Pharmaceuticals stock: The Xenon Pharmaceuticals ticker symbol is XENE. Is Xenon Pharmaceuticals stock a good investment? Should you buy shares of XENE? How do XENE's underlying business fundamentals look? Do top analysts think Xenon Pharmaceuticals is a good buy? Why has XENE's stock price moved recently? (Hint: Our stock market analysis website can help you understand if XENE is a good stock to buy).
Make your XENE trade: Decide if you will purchase XENE shares at the current market price or use a limit order to buy XENE shares at a particular price.
Keep tabs on your XENE investment: Create a watchlist to monitor your new investment in Xenon Pharmaceuticals shares.
Step 1: Choose where to buy Xenon Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy XENE shares.
A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Tech to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal information so you can invest in XENE stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Xenon Pharmaceuticals stock
After you have decided on the best place to buy Xenon Pharmaceuticals stock, it's absolutely critical to analyze their stock prior to buying, so you truly comprehend the risk as well as the upside.
Xenon Pharmaceuticals stock quick numbers
XENE Price
$40.50
1w %
1.55%
1y %
2.48%
5y %
332.23%
P/E
-14.84x
P/B
3.29x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$182.39M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$3.06B
Next Earnings
Jun 4, 2024
Next Dividend
N/A
Xenon Pharmaceuticals Due Diligence Checks
WallStreetZen was built to help part-time investors perform better fundamental analysis in less time.
Total XENE debt is lower than 5 years ago, relative to shareholder equity.
XENE has $638.08M in cash and short term investments. This is enough to cover its annual cash burn of $150.94M.
There are more short-term assets than short-term liabilities on the XENE balance sheet.
There are more short-term assets than long-term liabilities on the XENE balance sheet.
XENE has cash burn of 150944000. It has enough cash and short-term investments to cover this for at least one year.
Is it a good time to buy XENE stock, according to analysts?
Out of 8 Wall Street analysts who give recommendations on XENE, the consensus analyst rating on Xenon Pharmaceuticals is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest XENE Analyst Forecasts
Jason Gerberry, a top 17% analyst from Bank of America maintains XENE with a strong buy rating and raises their XENE price target from $52.00 to $56.00, on Jan 2, 2024.
Bank of America's Jason Gerberry raised their price target on Xenon Pharmaceuticals (NASDAQ: XENE) by 7.7% from $52 to $56 on 2024/01/02. The analyst maintained their Strong Buy rating on the stock.
Their 7.7% price target increase was to reflect the $345M equity raise closed on 2023/12/04, the analyst told investors.
Bank of America continues to view XEN1101* as a "best-in-class seizure asset with blockbuster potential," Gerberry added.
Footnotes
* XEN1101 is a treatment for epilepsy, major depressive disorder (MDD), and potentially other neurological disorders. [from here]
Stephen Willey, a bottom 5% analyst from Stifel Nicolaus maintains XENE with a strong buy rating and raises their XENE price target from $53.00 to $62.00, on Dec 18, 2023.
Brian Skorney, a top 14% analyst from Baird initiates coverage on XENE with a buy rating and announces their XENE price target of $63.00, on Dec 8, 2023.
Last year, XENE revenue was $0.00. In the last 4 year, XENE's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 28.56%.
No, Xenon Pharmaceuticals doesn't provide an income stream by paying out dividends.
XENE Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your XENE trade
You have two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are generally sufficient.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific price limit, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you want more info about buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Xenon Pharmaceuticals share?
As of Apr 26, 2024, it costs $40.50 to buy one share of Xenon Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.247 shares of XENE.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.